本页面由Tiger Trade Technology Pte. Ltd.提供服务

ORTHOCELL LTD

0.895
-0.005-0.56%
成交量:12.08万
成交额:10.79万
市值:2.43亿
市盈率:-17.16
高:0.915
开:0.900
低:0.880
收:0.900
52周最高:1.700
52周最低:0.855
股本:2.71亿
流通股本:1.94亿
量比:0.39
换手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-0.052
每股收益(LYR):-0.038
净资产收益率:-41.06%
总资产收益率:-20.97%
市净率:5.89
市盈率(LYR):-23.33

数据加载中...

公司资料

公司名字:
ORTHOCELL LTD
交易所:
ASX
成立时间:
2006
员工人数:
- -
公司地址:
Building 191,Murdoch University,90 South Street,Murdoch,Western Australia,Australia
邮编:
6150
传真:
61 8 9360 2899
简介:
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and related technologies for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, an autologous tenocyte implantation for chronic treatment degenerative tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.